Microbial recognition of target-cell glycoconjugates

Current Opinion in Structural Biology

Volumn 5, Issue 5, 1995, Pages 622-635

  Karlsson, Karl Anders ^a  

^a Department of Medical Biochemistry ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL TOXIN; CARBOHYDRATE; CARBOHYDRATE BINDING PROTEIN; CHOLERA TOXIN; ESCHERICHIA COLI ENDOTOXIN; GLYCOCONJUGATE; MEMBRANE ANTIGEN; PERTUSSIS TOXIN; SIALIC ACID DERIVATIVE; SIALIDASE; VEROTOXIN; VIRUS PROTEIN;

BACTERIAL INFECTION; BACTERIUM ADHERENCE; CELL MEMBRANE; COMPLEX FORMATION; CRYSTAL STRUCTURE; HELICOBACTER; HOST PARASITE INTERACTION; HUMAN; INFLUENZA VIRUS; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; PROTOZOON; REVIEW; TARGET CELL; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS INFECTION;

ANIMAL; BACTERIA; BACTERIAL ADHESION; BACTERIAL TOXINS; ENZYME INHIBITORS; GLYCOCONJUGATES; HEMAGGLUTININS, VIRAL; MEMBRANE GLYCOPROTEINS; MEMBRANE LIPIDS; MODELS, MOLECULAR; NEURAMINIDASE; PROTOZOA; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; VIRUSES;

EID: 0028787845     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-440X(95)80054-9     Document Type: Article

References (74)

1. Crystal structures of influenza virus hemagglutinin in complex with high-affinity receptor analogs
2. Structure of influenza hemagglutinin at the pH of membrane fusion
3. Insertion of a coiled-coil peptide from influenza virus hemagglutinin into membranes
4. Influenza hemagglutinin-mediated membrane fusion: influence of receptor binding on the lag phase preceding fusion
5. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding
6. Specificity of sialyl-sugar chain mediated recognition by the hemagglutinin of human influenza B virus isolates.
7. A sialic acid analogue acting as a receptor determinant for binding but not for infection by influenza C virus
8. Rational design of potent sialidase-based inhibitors of influenza virus replication
9. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro
10. Structure of influenza virus neuraminidase B/Lee/40 complexed with sialic acid and a dehydro analog at 1.8 Å resolution: implications for the catalytic mechanism
11. Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis
12. Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment
13. Binding to sialic acids is not an essential step for the entry of animal rotaviruses to epithelial cells in culture.
14. Activation of the Sendai virus fusion protein by receptor binding
15. The role of the ganglioside GD1a as a receptor for Sendai virus
16. Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane
17. Sphingolipid-dependent fusion of Semliki Forest virus with cholesterol-containg liposomes requires both the 3-hydroxyl group and the double bond of the sphingolipid backbone
18. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120
19. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential gp120 receptor
20. Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120
21. The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206–275
22. Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding
23. Interferon decreases cell surface expression of galactosyl ceramide, the receptor for HIV-1 gp120 on human colonic epithelial cells
24. Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colonic epithelial cells
25. Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide
26. Microbial interaction with animal cell surface carbohydrates
27. Crystal structures of membrane lipids
28. Crystallographic detection of a second ligand binding site in influenza virus hemagglutinin
29. Lactose binding to heat-labile enterotoxin revealed by X-ray crystallography
30. Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide
31. Structure of a pertussis toxin—sugar complex as a model for receptor binding
32. Crystal structure of the holotoxin from Shigella dystenteriae at 2.5Å resolution
33. Comparison of the B-pentamers of heat-labile enterotoxin and Verotoxin-1: Two structures with remarkable similarity and dissimilarity
34. Interaction of the Shiga-like toxin type 1 B-subunit with its carbohydrate receptor
35. Glycoproteins with Galα4Gal are absent from human erythrocyte membranes, indicating that glycolipids are the sole carriers of blood group P activities
36. Lipid modulation of glycolipid receptor function. Availability of Gal(α1–4)Gal disaccharide for Verotoxin binding in natural and synthetic glycolipids
37. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a Verotoxin 1-like disease in pigs
38. Neoglycolipid analogs of ganglioside GM1 as functional receptors of cholera toxin
39. Digalactosylceramide is the receptor for staphylococcal enterotoxin-B in human kidney proximal tubular cells
40. Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin
41. Galactose-binding site in Escherichia coli heat-labile enterotoxin (LT) and cholera toxin (CT)
42. Delineation and comparison of ganglioside-binding epitopes for the toxins of Vibrio cholerae, Escherichia coli, and Clostridium tetani: evidence for overlapping epitopes.
43. Comparison of the glycolipid-binding specificities of cholera toxin and porcine Escherichia coli heat-labile enterotoxin: identification of a receptor-active non-ganglioside glycolipid for the heat-labile toxin in infant rabbit small intestine
44. The Heat-Labile Enterotoxin of Escherichia coli Binds to Polylactosaminoglycan-Containing Receptors in CaCo-2 Human Intestinal Epithelial Cells
45. The Gal(α1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract
46. Glycoconjugate receptors for P-fimbriated Escherichia coli in the mouse. An animal model of urinary tract infection
47. Epithelial glucosphingolipid expression as a determinant of bacterial adherence and cytokine production
48. Oligosaccharide-receptor interaction of the Galα1-4Gal binding adhesin of Streptococcus suis. Combining site architecture and characterization of two variant adhesin specificities
49. An update on Helicobacter pylori
50. Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori
51. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens
52. An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium
53. b-containing glycoconjugates: A potential transgenic mouse model for studying Helicobacter pylori infection
54. Carbohydrate attachment sites for microbes on animal cells: aspects on the possible use of analogs to treat infections
55. Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA
56. The binding of Pseudomonas aeruginosa pili to glycosphingolipids is a tip-associated event involving the C-terminal region of the structural pilin subunit
57. The pili of Pseudomonas aeruginosa strains PAK and PAO bind specifically to the carbohydrate sequence βGalNAc(1–4)βGal found in glycosphingolipids asialo-GM1 and asialo-GM2
58. Adherence of Pseudomonas aeruginosa and Candida albicans to glycosphingolipid (asialo-GM1) receptors is achieved by a conserved receptor-binding domain present on their adhesins
59. Evidence for asialo GM1 as a corneal glycolipid receptor for Pseudomonas aeruginosa adhesion
60. Pseudomonas aeruginosa pili bind to asialo GM1 which is increased on the surface of cystic fibrosis epithelial cells
61. Binding of the galactose-specific Pseudomonas aeruginosa lectin, PA-1, to glycosphingolipids and other glycoconjugates
62. Piglet ileal mucus contains protein and glycolipid (galactosylceramide) receptors specific for Escherichia coli K88 fimbriae
63. Age-related resistance to 987P fimbria-mediated colonization correlates with specific glycolipid receptors in intestinal mucus in swine.
64. Type 1 fimbrial shafts of Escherichia coli and Klebsiella pneumoniae influence sugar-binding specificities of their FimH adhesins
65. High affinity binding of the Entamoeba histolytica lectin to polyvalent N-acetylgalactosaminides
66. A recombinant cystein-rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess
67. Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum binds specifically to sulfated glycoconjugates and to HepG2 hepatoma cells suggesting a role for this molecule in sporozoite invasion of hepatocytes.
68. N-acetylglucosamine-binding proteins on Plasmodium falciparum merozoite surface
69. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum
70. Stage-specific glycosphingolipids from amastigote forms of Leishmania (L.) amazoniensis. Immunogenicity and role in parasite binding and invasion of macrophages
71. Glycoprotein glycans that inhibit adhesion of Escherichia coli mediated by K99 fimbriae: Treatment of experimental colibacillosis
72. Characterization of gangliosides of epithelial cells of calf small intestine, with special reference to receptor-active sequences for enteropathogenic Escherichia coli K99
73. Sialyloligosaccharides from egg yolk as an inhibitor of rotaviral infection
74. Gastrointestinal infections. Editorial overview